IMR Press / CEOG / Volume 35 / Issue 1 / pii/1630638164381-25314903

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women of more advanced reproductive age with elevated serum follicle stimulating hormone (FSH) levels
Show Less
1 The University of Medicine and Dentistry of New Jersey
2 Robert Wood Johnson Medical School at Camden
3 Cooper Hospital/University Medical Center
4 Department of Obstetrics and Gynecology
5 Division of Reproductive Endocrinology & Infertility, Camden NJ (USA)
Clin. Exp. Obstet. Gynecol. 2008, 35(1), 13–15;
Published: 10 March 2008
Abstract

Purpose: To present data on the chances of pregnancy following in vitro fertilization embryo transfer, according to day 3 serum FSH and age groups in women ≥age 36. Materials and Methods: Data were analyzed according to three age groups (36-39, 40-42, ≥43) and five serum FSH ranges (≤10, 11-12, 13-14, 15-16, ≥17). Results: No live pregnancies were found in women aged ≥40 with serum FSH ≥15 mIU/mL but they were seen in women aged 36-39. Live deliveries were seen in women even ≥43 with serum FSH 13-14 mIU/mL. Conclusions: The higher the serum FSH and the greater the age, the lower the chances of successful conception. However, reasonable pregnancy rates are found in women aged ≥36 with serum FSH ≥15 mIU/mL and a live delivered pregnancy rate of about 10% can occur even in women aged ≥ 43 with mild FSH elevations [11-14].
Keywords
Advanced reproductive age
Diminished egg reserve
In vitro fertilization
Serum FSH
Share
Back to top